Experience with the Continuous Glucose Monitoring System® in a Medical Intensive Care Unit
- 1 June 2004
- journal article
- research article
- Published by Mary Ann Liebert Inc in Diabetes Technology & Therapeutics
- Vol. 6 (3), 339-347
- https://doi.org/10.1089/152091504774198034
Abstract
Strict glycemic control improves clinical outcomes in critically ill patients. However, practical tools for frequent monitoring of blood glucose (BG) levels in the intensive care unit (ICU) are limited. The Continuous Glucose Monitoring System® (CGMS, Medtronic MiniMed, Northridge, CA) is currently approved for detecting glycemic excursions in outpatients with diabetes mellitus. The use of this device has never been carefully examined in the inpatient setting. This preliminary study was designed to investigate the accuracy of the CGMS in critically ill patients admitted to a medical ICU (MICU). Subjects at risk for hyperglycemia were recruited from among all patients admitted to our MICU. CGMS sensors were implanted for up to 72 h. Study subjects wore between one and five consecutive sensors. Four or more standard capillary BG readings were recorded per 24 h. All paired meter-sensor (M-S) readings were used both for CGMS calibration and for data analysis. Twenty-two MICU patients wore 41 CGMS sensors, yielding 546 M-S BG pairs. Overall, the Pearson correlation coefficient ( r ) was 0.88, with a mean M-S difference of 3.3 ± 26.7 mg/dL (0.6 ± 17.4%) and a mean absolute M-S difference of 19.7 ± 18.3 mg/dL (12.8 ± 11.9%). Clarke Error Grid analysis categorized 98.7% of the M-S pairs within "clinically acceptable" zones A and B. The CGMS is promising for potential use in critically ill patients. If validated in larger studies, the device could serve as a useful research tool for investigating the role of hyperglycemia (and strict glycemic control) in ICU patients. If further developed as a "real-time" glucose sensor, CGMS technology could ultimately prove clinically useful in the ICU, by decreasing nursing workload and/or by providing alarm signals for impending glycemic excursions.Keywords
This publication has 19 references indexed in Scilit:
- Intensive Insulin Therapy in Critically Ill PatientsThe New England Journal of Medicine, 2001
- The MiniMed Continuous Glucose Monitoring SystemDiabetes Technology & Therapeutics, 2000
- Efficacy and Reliability of the Continuous Glucose Monitoring SystemDiabetes Technology & Therapeutics, 2000
- Continuous Glucose Monitoring in Previously Unstudied Population SubgroupsDiabetes Technology & Therapeutics, 2000
- Performance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home UseDiabetes Technology & Therapeutics, 2000
- Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical proceduresThe Annals of Thoracic Surgery, 1999
- Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitusBMJ, 1997
- Glucose Control Lowers the Risk of Wound Infection in Diabetics After Open Heart OperationsThe Annals of Thoracic Surgery, 1997
- Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 yearJournal of the American College of Cardiology, 1995
- Fingerstick Glucose Determination in ShockAnnals of Internal Medicine, 1991